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Background: To determine incidence and remission of UI as well as changes in UI prevalence in the Norwegian
EPINCONT surveys.
Methods: The EPINCONT surveys were conducted in the county of Nord-Trøndelag, Norway, as part of two large
cross-sectional health surveys (HUNT2 and HUNT3) in 1995 – 1997 (EPINCONT1 (E1)), and 2006 – 2008 (EPINCONT2
(E2)). EPINCONT collected information about prevalence of UI, as well as information about type and severity of UI.
Results: A 16% relative increase in UI prevalence was found in 11 years. The women who answered E2 were
significantly older, had a higher BMI and higher prevalence of diseases such as asthma, diabetes and angina
compared with the women who answered E1.
The incidence of UI was 18.7%. Increase in BMI (OR 1.03, 95% CI: 1.02 – 1.04), weight increase (OR 1.29 (95% CI: 1.14
– 1.45) for gaining 3 – 10 kilos and OR 1.71 (95% CI: 1.47 – 1.99) for gaining 10 kilos or more) and parity (OR 1.37
(95% CI: 1.04 – 1.79) for 1 childbirth, OR 1.28 (95% CI: 1.03 – 1.61) for 2 childbirths, and OR 1.56 (95% CI: 1.26 – 1.95)
for 3 or more childbirths when participating in E2) were all found to be associated with increased odds of incident
UI in adjusted regression analyses. Increasing age reduced the odds of incident UI. The 11 year remission of UI was
34.1%. Increasing age (OR 0.98, 95% CI: 0.98 – 0.99), increasing BMI (OR 0.96, 95% CI: 0.95 – 0.98) and large weight
gains of 10 kilos or more (OR 0.69, 95% CI: 0.54 – 0.88) were all associated with reduced remission of UI.
Conclusion: Crude UI prevalence increased between the studies. Changes in known risk factors for UI such as age,
BMI, weight and parity could explain some of the relative increase in prevalence, and were also found to be
associated with either incidence of UI, remission of UI or both.
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HUNTBackground
There are abundant studies on prevalence of urinary in-
continence (UI), and a large prevalence span has been
reported [1]. Few cohort studies have reported change in
prevalence [2-4], and repeated cross- sectional studies
based on entire adult female populations (20+) are to
the best of our knowledge scarce [5]. Studies reporting
incidence of UI are increasing in number, and a recent
review of studies on overactive bladder and UI found* Correspondence: marithelen@gmail.com
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reproduction in any medium, provided the orannual incidence rates between 0.9 and 19% [6]. Differ-
ences in study design [7-9], definitions used [2,10] and
interval between studies [3,11] could possibly explain
some of the large variation.
The Norwegian HUNT study (The Nord-Trøndelag
Health Study) can provide useful information about
changes in UI prevalence as well as incidence and remis-
sion of UI in large adult female populations, since all
women aged 20 years or older in a Norwegian county
were invited to participate at two different points in time
(1995 - 1997 and 2006 - 2008). The UI part of HUNT,
the EPINCONT substudy (Epidemiology of Incontinence
in the County of Nord-Trøndelag) was included on bothl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions to determine severity of UI [12,13] as well as
definitions of UI in concordance with the recent recom-
mendations from the International Continence Society
(ICS) [14]. As EPINCONT is part of a large prospective
general health study extensive information about other
health and life style topics is provided. This provides op-
portunities for assessing predictors for change in UI
prevalence, incidence and remission of UI, as well as
clarifying the roles of known or less determined risk fac-
tors for UI, such as diabetes.
The current article presents prevalence as well as inci-
dence and remission data on UI in the Norwegian
EPINCONT population, with two data points approxi-
mately 11 years apart. We also investigate associations
with some known risk factors for UI such as age, BMI,
parity and diabetes, and discuss their possible influence
on the changes found.
Methods
The Norwegian HUNT study was performed in the
county of Nord-Trøndelag at three different occasions,
baseline in 1984 - 1986 (HUNT1), and two follow up
surveys in 1995 -1997 (HUNT2, baseline for EPINCONT)
and 2006 - 2008 (HUNT3). The incontinence part
(EPINCONT) was first introduced in the HUNT2 survey
(1995 - 1997, EPINCONT1 (E1)), with follow up ques-
tions in HUNT3 (2006 - 2008, EPINCONT2 (E2)). Every-
one living in the county aged 20 years or older was invited
by mail to participate. Along with the invitation was
Questionnaire 1 (Q1). Screening stations were set up on
different locations in the county, and those who chose to
participate were to bring Q1 with them to one of these
screening stations. At the screening station the partici-
pants underwent some clinical examinations, and add-
itional information was gathered by interviewing the
participants as well as providing everyone with Question-
naire 2 (Q2), which should be filled in at home and then
returned by mail in a prepaid envelope. The EPINCONT
part was included in Q2. Those answering affirmative to
some specific questions in Q1 also received Questionnaire
3 (Q3) to collect depth information on that specific topic,
e.g. diabetes. Some of the information collected by ques-
tionnaires in HUNT2 was collected by interviews at the
screening stations in HUNT3, e.g. parity.
The EPINCONT part consisted of the same questions
on both occasions. The women first answered yes or no to
the entry question “Do you have involuntary loss of
urine”? Severity of UI was then determined by asking the
women about amount (3 levels) and frequency (4 levels)
of leakage. Amount and frequency were multiplied and
Sandvik’s Severity index calculated in order to classify the
women as having slight, moderate, severe or very severe
UI [13]. Due to a technical error the question aboutamount of leakage only contained two levels in approxi-
mately 25% of the questionnaires in the E1 survey, and
hence these women are missing on the 4-level Severity
index analyses. Information about type, duration, impact
of UI and help seeking due to UI were also collected [15].
Women participating in E2 also answered a question
about treatment of UI.
The women were defined as incontinent if they an-
swered affirmatively to the entry question about any invol-
untary leakage of urine. Those who answered no to this
question or had a missing answer were still included as in-
continent if they provided answers to the questions about
type, frequency and amount of leakage (all three had to be
answered), in accordance with the definitions used in pre-
vious publications from the E1 survey [15]. Incidence of
UI was defined as having no UI in E1 and having UI in E2,
whilst remission of UI was defined as having UI in E1 but
not in E2. Average yearly incidence and remission of UI
were calculated to compare the results from EPINCONT
to existing literature. Average yearly incidence/remission
of UI was determined by dividing the incidence/remission
by the years passed between surveys.
For the crude prevalence analyses, women answering
E1 or E2 were analysed separately (Tables 1, 2 and 3),
whilst in the analyses of incidence and remission of UI
longitudinal data was used; hence only women who par-
ticipated in both EPINCONT surveys were included in
these analyses. Analyses presented in Tables 2, 3, 4 and
5 are limited to the women who had given a valid an-
swer to the incontinence questions in one or both of the
EPINCONT surveys.The women were analysed in 5 -
year age groups with regards to crude prevalence of any
UI as well as analyses on type and severity of UI. For
analyses of incidence and remission (Table 4) the women
were divided into 3 groups 20 - 39, 40 - 54, 55+ years of
age (age when participating in E1 was used). Known risk
factors for UI such as age, BMI and parity were adjusted
for in the multivariate regression analyses. Based on pre-
vious publications [16] and preliminary analyses smok-
ing was also included amongst the adjustment variables
(Table 5). Age, BMI and smoking status were obtained
from the E1 survey whilst parity was obtained from E2,
hence age, BMI and smoking status could be investi-
gated as possible risk factors for incidence and remission
of UI. Parity (E2) and weightchange could have occurred
after incidence/remission of UI, so it is only possible to
investigate associations between these variables and inci-
dence/remission of UI. Diabetes was investigated separ-
ately as a risk factor for incidence and remission of UI,
but was not included in the final regression model.
A new category was added to the smoking variable in
HUNT3 compared with HUNT2; -smoking occasionally.
Those who reported smoking occasionally were included
as current smokers in all analyses.
Table 1 Participation rates for the HUNT and EPINCONT surveys
HUNT2 HUNT3 Both HUNT2 and HUNT3
N % N % N %
Women invited to HUNT 47 177 100.0 47 415 100.0 35 263 100.0
Answered Q1 34 662 73.5 27 758 58.5 20 465 58.0
Attended screening (source population EPINCONT) 34 548 73.2 27 691 58.4 20 417 57.8
Answered EPINCONTa 27 992 81.0 21 804 78.7 14 606 71.5
a: Percentage of source population.
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The main study had ethical recommendation from both
the Regional and National Ethics Review Boards. Attend-
ance was completely voluntary and subjects gave and ex-
tensive written consent to use of the collected material.
The survey was also approved by the Norwegian Data
Inspectorate.
Statistics
Data were analysed using PASW Statistics version 18.0.
Statistical significance was accepted at a 5% level (p <
0.05). Age and BMI of the participants in E1 and E2
were presented as means with Standard Deviations (SD).
Chi - square tests were used to compare characteris-
tics of the women who had participated in E1, E2 or
both. Mean age and BMI in E1 and E2 were compared
with t – tests.
Logistic regression analyses were performed with inci-
dence or remission as dependent variables. Women who
were continent and women who were incontinent on
both occasions were used as reference categories for in-
cidence and remission of UI respectively. Among the ad-
justment variables age and BMI were used as continuous
variables. The rest of the adjustment variables were
treated as categorical and the following reference values
were used: nulliparous women, weight change between -
3 /+3 kilos and no smoking. Odds ratios (ORs) with cor-
responding 95% confidence intervals (CI) were the effect
measures.
Results and discussion
Results
Table 1 displays participation rates for the two HUNT
surveys as well as the EPINCONT parts, E1 (1995-1997)
and E2 (2006-2008). Most women who attended the
screening stations and received Q2 (containing the
EPINCONT questions) chose to participate and thus re-
sponse rates were close to 80% in both EPINCONT
surveys.
Approximately 11 years after the E1 survey the crude UI
prevalence had increased significantly from 25.0% (N = 7
008) in E1 to 29.0% (N = 6 332) in E2 (p < 0.001). The
women who participated in E2 were older, with a mean
age of 53.0 years (± 15.9 SD) compared with 49.3 years (±17.1 SD) in E1 (p < 0.001). The mean age of the women
participating in both surveys was 57.6 (± 13.2 SD) years of
age. A rise in mean BMI was found, from 26.21 (± 4.54
SD) in E1 to 26.96 (± 4.84 SD) in E2 (p < 0.001). The mean
BMI for women who attended both studies was 27.19 (±
4.73 SD).
Figure 1 shows crude UI prevalence in 5-year age
groups. In E1 a peak was observed in the group 50 –
54 years of age, the peak was followed by a decline and
around 62 years of age the prevalence started to increase
again. A similar pattern was observed among partici-
pants in E2, but the overall prevalence was higher, the
peak occurred at a younger age, and the decline in E2
came at the age of the peak in E1.
Table 2 displays characteristics of the women partici-
pating in E1, E2 as well as the women who participated
in both surveys. The women who participated in E2
were significantly older, had a higher BMI as well as
more overweight and obesity, and they consumed more
alcohol compared with the women in E1. Other statisti-
cally significant differences were more asthma, chronic
cough, diabetes and stroke in the participants in E2, they
also had less angina, fewer hysterectomies, while nul-
liparous women were more common in E1. The women
who participated in both EPINCONT surveys, had even
more overweight and obesity as measured by BMI, they
smoked less and consumed more alcohol compared with
all the E2 women. They also had a higher prevalence of
angina, heart attack, stroke and diabetes compared with
all the E2 women, while fewer of them were nulliparous.
Prevalence of any UI, type of UI and severity of UI in
5 - year age groups are presented in Table 3 for the E1
and E2 women. The women in E2 had higher prevalence
of UI in all age groups except for the groups 50 – 54
and 75 - 79 years of age (see also Figure 1). The differ-
ences in prevalence of any UI were statistically signifi-
cant in most age groups. Stress UI was overall the most
prevalent type of UI in both E1 and E2, followed by
mixed, urgency and other UI. Mixed UI became the
most prevalent type of UI after 60 years of age in both
E1 and E2. The type distribution among E1 and E2
women was relatively similar, but was significantly differ-
ent in the age groups 45 - 59, 65 - 69 and 75 - 79 years,
with less stress UI among E2 women compared with the
Table 2 Characteristics of the women participating in EPINCONT1 (E1, 1995 – 1997), EPINCONT2 (E2, 2006 – 2008) and
both EPINCONT surveys
E1 E2 Pb E1 and E2c Pd
Participantsa N = 27 992 N = 21 804 N = 14 606
N % N % N %
Age distribution (years) <0.001 <0.001
20 – 34 6 630 23.7 3 113 14.3 494 3.4
35 – 49 8 671 31.0 6 132 28.1 3 967 27.2
50 – 64 6 589 23.5 7 352 33.7 5 910 40.5
65 + 6 101 21.8 5 207 23.9 4 235 29.0
BMI <0.001 <0.001
Underweight (≤ 18.4) 267 1.0 182 0.8 89 0.6
Normal (18.5 – 24.9) 12 169 43.8 8 212 37.8 5 095 35.0
Overweight (25.0 – 29.9) 10 301 37.1 8 260 38.0 5 839 40.1
Obese (≥ 30) 5 028 18.1 5 072 23.3 3 538 24.3
Self-perceived health status 0.038 <0.001
Bad 449 1.6 274 1.3 176 1.2
Not entirely good 7 312 26.3 5 569 26.4 4 007 28.4
Good 15 488 55.8 11 834 56.1 7 935 56.2
Excellent 4 505 16.2 3 424 16.2 2 006 14.2
Smoking 0.095 0.009
Not smoking 19 651 71.2 15 273 71.4 10 395 73.1
Smoking 7 952 28.8 5 975 28.1 3 818 26.9
Glasses alcohol last 2 weeks <0.001 0.016
0 7 002 34.0 5 947 32.3 3 805 30.9
1 – 4 11 425 55.5 9 421 51.2 6 356 51.6
>5 2 160 10.5 3 047 16.5 2 147 17.4
Parity <0.001 <0.001
0 3 931 14.2 2 633 12.1 895 6.1
1 3 229 11.7 2 090 9.6 1 150 7.9
2 8 951 32.3 7 633 35.1 5 446 37.3
3+ 11 595 41.9 9 415 43.2 7 101 48.7
Hysterectomy 1 773 13.4 2 040 10.6 <0.001 1 574 11.2 0.111
Asthma 2 390 8.6 2 318 10.6 <0.001 1 534 10.5 0.694
Chronic cough 829 3.0 881 4.1 <0.001 605 4.2 0.615
Diabetes 739 2.6 816 3.7 <0.001 613 4.2 0.029
Angina 979 3.5 534 2.4 <0.001 415 2.8 0.021
Heart attack 415 1.5 327 1.5 0.893 258 1.8 0.047
Stroke 459 1.6 474 2.2 <0.001 368 2.5 0.032
a: Women with a valid answer to the entry question in EPINCONT.
b: p - values from chi - square tests comparing the women who participated in E1 with those who participated in E2.
c: Variables from HUNT3 were used.
d: p - values from chi - square tests comparing women who participated in E2 with those who participated in both E1 and E2.
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E2, followed by slight, severe and very severe UI. Slight UI
was most prevalent in the younger age groups, and mod-
erate UI was the most prevalent grade of severity after
50 years of age in E2 and after 55 years in E1. In three agegroups (40 – 44, 50 – 54 and 55 – 59 years of age) there
were significant differences in severity distribution in E1
compared with E2, with less severe symptoms in E2.
Table 4 shows incidence and remission of UI by type and
severity for the women participating in both EPINCONT
Table 3 Prevalence of any UI, type and severity of UI in EPINCONT1 and EPINCONT2 in 5 – year age groups
Age -
group
Survey Any UI p Type of UI P Severity of UI p
N Stress Urgency Mixed Other N Slight Moderate Severe Very Severe
N % % % % % % % % %
20 - 24 E1 222 11.2 0.951 218 43.1 12.4 30.3 14.2 0.326 172 53.5 36.6 8.1 1.7* 0.220
E2 116 11.3 116 46.6 18.1 24.1 11.2 113 63.7 30.1 6.2 0*
25 - 29 E1 320 15.0 0.001 318 54.4 11.9 26.4 7.2 0.139 229 55.5 39.3 3.9 1.3* 0.310
E2 173 20.0 173 54.9 17.9 19.1 8.1 170 61.8 35.3 2.9 0*
30 - 34 E1 479 19.1 <0.001 479 57.6 9.8 26.7 5.8 0.595 343 59.5 38.2 1.7 0.6* 0.756
E2 299 24.5 299 53.2 12.0 29.1 5.7 297 63.3 35.0 1.3 0.3*
35 - 39 E1 576 21.0 <0.001 570 59.5 6.8 28.8 4.9 0.571 432 57.6 39.6 2.5 0.2* 0.640
E2 528 29.3 525 58.1 9.1 28.2 4.6 516 57.9 38.8 3.3 0*
40 - 44 E1 728 24.6 <0.001 724 61.0 8.3 27.3 3.3 0.230 511 51.5 42.7 5.1 0.8* 0.031
E2 633 30.5 633 56.9 10.4 30.2 2.5 624 53.7 43.9 2.1 0.3*
45 - 49 E1 851 28.7 0.098 849 63.3 6.5 27.7 2.6 <0.001 594 52.2 39.7 6.6 1.5 0.166
E2 695 30.8 691 49.8 11.3 36.2 2.7 681 47.9 45.7 5.4 1.0
50 - 54 E1 832 30.3 0.039 828 54.2 7.6 36.0 2.2 0.034 554 45.7 43.0 10.5 0.9* 0.039
E2 663 27.6 660 47.1 10.5 40.0 2.4 645 46.2 47.0 6.0 0.8*
55 - 59 E1 567 28.1 0.371 558 50.9 9.7 36.4 3.0 0.023 394 36.5 49.7 11.7 2.0 0.032
E2 725 29.4 721 43.7 14.0 38.3 4.0 694 44.5 46.0 8.4 1.2
60 - 64 E1 480 26.3 0.008 474 40.9 10.5 45.4 3.2 0.207 297 35.4 45.5 16.5 2.7 0.091
E2 746 30.0 741 38.6 14.7 44.0 2.7 720 35.8 51.0 11.1 2.1
65 - 69 E1 513 27.9 0.240 500 36.0 14.6 44.8 4.6 0.009 312 22.4 51.6 20.8 5.1 0.052
E2 529 29.6 526 30.0 16.7 51.3 1.9 509 29.5 51.1 16.3 3.1
70 - 74 E1 572 31.6 0.302 563 32.9 15.5 46.4 5.3 0.159 390 21.5 50.8 22.6 5.1 0.307
E2 458 33.4 456 27.4 18.4 50.0 4.2 438 23.5 52.3 21.5 2.7
75 - 79 E1 481 34.9 0.864 474 32.9 19.2 40.9 7.0 0.024 317 22.1 44.5 25.9 7.6 0.920
E2 367 34.6 362 25.7 17.1 51.4 5.8 342 21.1 45.9 26.6 6.4
80 + E1 386 36.0 0.037 366 29.8 19.7 41.0 9.6 0.197 238 14.7 42.9 35.7 6.7 0.713
E2 400 40.4 389 23.7 20.6 47.3 8.5 370 16.5 44.6 31.4 7.6
Total E1 7 008 25.0 <0.001 6921 49.4 10.9 35.0 4.7 <0.001 4 784 41.9 43.5 12.1 2.5 0.006
E2 6 332 29.0 6292 42.9 13.9 39.3 4.0 6119 42.1 45.5 10.5 1.9
*: ≤ 5 participants.
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the age on participation in E1). A total of 2 054 (18.7%)
women reported incident UI whilst 1 238 (34.1%) reported
remission of UI. The average yearly incidence rate was
1.7%. Incidence of UI was highest in the youngest women
(20 - 39 years (E1)). Most of the women with incident UI
experienced stress UI (46.6%), followed by mixed (33.9%),
urgency (15.0%) and other UI (4.6%). After 55 years of age
(E1) incident UI was mostly of mixed type. Slight severity
was the most common grade of severity, with 50.6% of the
women with incident UI reporting this severity degree.
After 55 years of age (E1), moderate UI was the most
prevalent grade of severity, 48.5%. The average yearly inci-
dence rate was 3.1%. Remission was highest in women
younger than 55 (E1), and most women who experiencedremission had stress type and slight severity at baseline in
E1. This was the case for all age groups.
Table 5 displays adjusted odds ratios for incidence and
remission of UI. Parity and increasing BMI were found
to be associated with increased odds of incident UI,
whilst increasing age reduced the odds of incident UI,
with a 1% reduction in incident UI for each year increase
in age. Weight gain was also associated with more inci-
dence of UI, and a certain dose response effect was
found. Increasing age and BMI, as well as large weight
gains (≥ 10 kilos) were associated with reduced odds for
remission of UI.
Separate logistic regression analyses were performed
to investigate diabetes as a risk factor for incidence and
remission of UI. Having diabetes in E1 was not found to
Table 4 Incidence and remission of any UI and distributions by type and severity in EPINCONT
Any UI Type of UI Severity of UI
Stress Urgency Mixed Other Slight Moderate Severe Very Severe
N % N % N % N % N % N % N % N % N %
Incidence of UI
Age / yearsa
20 – 39 897 22.3 493 55.1 108 12.1 262 29.3 32 3.6 536 61.1 322 36.7 16 1.8 3 0.3
40 – 54 665 15.9 300 45.4 105 15.9 228 34.5 28 4.2 323 50.1 296 45.9 23 3.6 3 0.5
55 + 492 17.9 157 32.4 93 19.2 201 41.5 33 6.8 142 31.0 222 48.5 80 17.5 14 3.1
Total 2 054 18.7 950 46.6 306 15.0 691 33.9 93 4.6 1 001 50.6 840 42.4 119 6.0 20 1.0
Remission of UI
Age / yearsa
20 – 39 322 37.2 178 56.2 33 10.4 73 23.0 33 10.4 152 64.7 76 32.3 6 2.6 1 0.4
40 – 54 620 36.8 384 62.1 48 7.8 161 26.1 25 4.0 258 60.3 153 35.7 17 4.0 0 0
55 + 296 27.4 156 54.0 26 9.0 91 31.5 16 5.5 93 46.3 87 43.3 16 8.0 5 2.5
Total 1 238 34.1 718 58.7 107 8.7 325 26.6 74 6.0 503 58.2 316 36.6 39 4.5 6 0.7
a: Age when participating in EPINCONT1 (E1).
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mission of UI. However, getting diabetes between E1
and E2 was found to reduce the odds of remission sig-
nificantly before adjustments (OR 0.68, 95% CI: 0.48 –
0.96). The association was not significant after adjust-
ments for age, BMI, weight change, parity and smoking
(OR 0.74, 95% CI: 0.51 – 1.07).
Discussion
In this follow-up study of the large Norwegian E1 survey
we found a 16% relative increase in crude UI prevalence,Table 5 Adjusteda Odds Ratios (OR) for incidence and remissi
and EPINCONT2 (E2)
Incidence of UI
N = 2 054 OR 95% CI
Age (E1) 2 054 0.99 0.99 – 1.00
BMI (E1) 2 046 1.03 1.02 – 1.04
Weight Change (kg)
No change (-3 / +3) 651 1.0
Loss: 3 - 10 209 1.01 0.85 – 1.20
Loss: > 10 70 1.28 0.96 – 1.72
Gain: 3 - 10 720 1.29 1.14 – 1.45
Gain: > 10 377 1.71 1.47 – 1.99
Parity (E2)
0 111 1.0
1 166 1.37 1.04 – 1.79
2 736 1.28 1.03 – 1.61
3 + 1 040 1.56 1.26 – 1.95
Smoking (E1) 541 0.93 0.83 – 1.04
a: All OR are adjusted for all the other variables presented in the table.
*: p < 0.05. **: p < 0.01. ***: p < 0.001.from 25.0% to 29.0% in approximately 11 years. The in-
cidence and remission of UI among those participating
in both surveys were found to be 18.7% and 34.1% re-
spectively. Both incidence and remission were found to
be highest in women 20 – 39 years of age. Adjusted lo-
gistic regression analyses identified known risk factors
such as BMI, weight change and parity to be influential
on the odds ratios for incidence and remission of UI. In-
crease in age was found to be associated with reduced
incidence and remission of UI, whilst increase in BMI
increased the odds of incident UI and reduced the oddson of UI in women participating in both EPINCONT1 (E1)
Remission of UI
N = 1 238 OR 95% CI
*** 1 238 0.98 0.98 – 0.99 ***
*** 1 233 0.96 0.95 – 0.98 ***
475 1.0
168 1.07 0.85 – 1.34
52 1.33 0.91 – 1.93
*** 395 0.90 0.76 – 1.06
*** 130 0.69 0.54 – 0.88 **
50 1.0
* 89 0.90 0.58 – 1.40
* 450 0.97 0.67 – 1.40
*** 646 0.96 0.67 – 1.38
337 1.09 0.92 – 1.28
Figure 1 Prevalence (%) of UI in EPINCONT1 (E1) and
EPINCONT2 (E2) by 5-year age groups.
Ebbesen et al. BMC Urology 2013, 13:27 Page 7 of 10
http://www.biomedcentral.com/bmc/13/27of remission. Increasing weight gain increased the inci-
dence of UI, with a dose response effect. Weight gains
above 10 kilos reduced the odds of remission.
One of the strengths of the EPINCONT study is the
substantial number of women (14 606) participating in
both surveys. The study is population based, and all
adult women 20 years of age and older were invited to
participate. This makes it reliable to transfer knowledge
back to the entire adult female population. In addition
the EPINCONT study is part of a larger health study
(HUNT) which provides extensive information about
other health topics in these women, which could be
helpful to understand changes in UI status. EPINCONT
uses definitions of UI as recommended by the ICS [14]
and a validated Severity index [13].
The surveys have some limitations. The definition
chosen for any UI in EPINCONT is in accordance with
ICS guidelines. This is a broad definition, and hence
women with clinically unimportant UI would also be
identified and included in our analyses. Investigating the
level of bother in the women with incident UI, we found
that 70% of the women with incident UI experienced no
bother or only a small nuisance due to their UI. Selec-
tion bias could also be a limitation to our study, due to
the decline in participation in HUNT3. Of the invited
women 58.5% participated in HUNT3. However, the
response rate to the EPINCONT part of the study
remained quite high (78.7%) compared with a response
rate of 81.0% in E1. Drop out of women before they re-
ceived Q2 could induce falsely lower prevalence and in-
cidence as well as a higher remission rate of UI, since
healthier people tend to participate to a higher degree in
studies like these. Using our data to compare women
who only participated in E1 with those who participated
twice, the women who participated only in E1 smoked
more and were younger (mean age 43.3 years compared
with 46.4 years). In addition there were only small and
non-significant differences with regard to diseases suchas diabetes, asthma and myocardial infarction. The
prevalence of UI was lower in the group of women par-
ticipating only in E1 (22.3% compared with 24.9% in
those participating twice. Details are not shown). This
indicates that UI prevalence is not underestimated des-
pite a lower attendance in HUNT3. Another limitation
is the 11 year period between the two studies. Other
incidence and remission studies which have been
conducted over a shorter time span have found quite
high incidence and remission rates [17,18] indicating
that UI is a fluctuating condition that comes and goes.
Thus, the long time passed between the two surveys,
and only two points of data collection, makes it difficult
to discover short time changes in UI status, type and se-
verity, and could partly explain the low incidence and re-
mission rates found.
The prevalence of UI found in the two EPINCONT
surveys within the range of reported prevalence in other
longitudinal studies, where prevalence’s between 15 [2] -
66% [17] have been found. Some of this span could be
due to different age groups included in the studies.
Prevalence curves from the two EPINCONT surveys
show approximately the same pattern with the highest
prevalence of UI in the older age groups. A similar
prevalence pattern was found in another longitudinal
cohort study from Norway [19]. Since the EPINCONT
surveys include women 20 years or older a lower
prevalence of UI is expected compared with studies
conducted on older women [8,18]. The majority of
women in both E1 and E2 were found to have stress UI
of moderate severity. Stress UI is known to be the most
prevalent type of UI in young and middle-aged women,
whilst urgency and mixed UI increases with age [15,20].
Since most women in our surveys were below 60 years
of age, stress UI was expected to be the most prevalent
type. This type distribution is also in accordance with
other studies [19,21], and compared with another Nor-
wegian longitudinal study [22], the EPINCONT women
had the same type and severity distribution for the
equivalent age group, though more of the EPINCONT
women reported a new onset UI of severe degree.
During the eleven years between the two EPINCONT
surveys we found a 16% relative increase in crude UI
prevalence from 25.0% to 29.0. Repeated cross – sec-
tional studies including entire adult female populations
(20 +) is the only way to investigate populational
changes in UI prevalence, and to our knowledge the
National Health and Nutrition Examination Survey
(NHANES study) is the only study who have published
changes in UI prevalence in a representative sample of
the adult female population [5]. The change found in
crude UI prevalence in EPINCONT is in accordance
with the findings from the NHANES study, with relative
increases of 16.0% in 11 years and 7.9% in 6 years,
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could either represent an actual increase in UI preva-
lence in adult females, be due to increase in known risk
factors for UI, or be caused by to the lower attendance
in HUNT3, making selection bias more likely to occur.
Known risk factors for UI such as age [23,24], BMI [25]
and parity [26] were found to be significantly different in
E1 and E2, and the low participation rate in HUNT3
could represent a potential selection bias if the women
who had UI were more prone to participate in the E2
study. The UI prevalence was as previously mentioned
higher in the E1 women who also participated in E2
(24.9%) compared with the prevalence in the E1 women
who just participated in E1 (22.8%). However, the preva-
lence in the women participating twice were closer to
the total prevalence in HUNT2 (25.0%), and given the
good response rate in HUNT2 selection bias is less likely
to be a major determinant of increased prevalence.
An average yearly incidence rate of 1.7% puts the
EPINCONT study in the lower range compared with in-
cidence reported in other longitudinal studies [7,27,28].
Not many studies exist which have been conducted on a
similar population and have used the same UI definition:
defining an incident case of UI as someone who reports
no leakage at baseline and “any leakage” regardless of
amount and frequency at follow-up. In one similar study
conducted in Gothenburg on women older than 20 ran-
domly selected from the Swedish National population
register, an incidence rate of 21% in 16 years was found,
providing an average yearly incidence of 1.3% [2]. That
study also found the highest incidence of UI to occur in
the youngest women (20 - 34 years) which is similar to
our study. A study on women 20 – 89 years of age
conducted in Austria showed a yearly incidence of any
UI of 3.9% [3]. The incidence found in the EPINCONT
women is quite similar to that found in Sweden for the
same age group, with only two data points separated by
a long time span. Many of the other longitudinal studies
on UI have included a limited age span [4,10,28] or re-
stricted the definition of “any UI” to apply only if the
participants reported a certain frequency of leakage
[3,7,10,18]. Such differences in age and UI definitions
might partly explain the wide range in incidences from
0.9% [29] per year to 19% [17]. The EPINCONT women
who became incontinent between studies primarily got
stress UI of slight severity. In women older than 55
mixed UI of moderate severity was more common. This
type and severity distributions for new onset UI were
similar to the ones found in another longitudinal cohort
study from Norway [22]. In the large Nurses’ Health
Study two year incidence of frequent UI was also pri-
marily stress UI, followed by mixed and other UI [7].
And in another publication from the same cohort an in-
creased risk of severe UI in women older than 60 years,as well as an increased risk for urgency and mixed type
of UI was reported [30], which corresponds well with
our findings.
The average yearly remission rate of 3.1% in the
EPINCONT women also falls into the lower range
compared with existing literature, where reported yearly
remission rates lies between 2.1% [2] and 27.8% [10].
Another similar study found a remission rate of 2.9% [3],
though defining UI as any involuntary leakage during
the last month. Remission rate in white women in the
Nurses’ Health Study was a little higher, 4.5%, but did
not include women younger than 37 years of age [31].
Other studies have identified age [32], BMI [25,33],
weight gain [25,33], oral contraceptive use [34] and
physical function and psychiatric illness [28,35] among
risk factors associated with incident UI. In the current
study we identified BMI as a risk factor for incident UI,
whilst weight change and parity were found to be associ-
ated with incident UI. Weight change has been found to
be influential on UI status, and weight loss programs
have proven to be an effective way to improve UI and
increase remission of UI [25,36,37]. There was an associ-
ation between weight gain above 10 kilos and incidence
and remission of UI in the EPINCONT women, where
incidence of UI was increased and remission of UI was
reduced with a weight gain of 10 kilos or more. How-
ever, we found no significant association between UI
(neither incidence nor remission of UI) and weight loss
between the two EPINCONT surveys. This could be due
to few participants in the largest weight loss group (lack
of power) or other factors difficult to control in cross -
sectional studies (such as loss of weight associated with
serious disease). In previous publications from the E1
survey we found diabetes to be significantly associated
with prevalent UI [38,39]. Having diabetes in E1 was not
found to be associated with incidence or remission of UI
in neither bivariate nor multivariate analyses. This is in
accordance with findings by Waetjen et al, who found
diabetes to be associated with prevalence of any UI (OR
2.34, 95% CI: 1.21 – 4.55) but not incidence of any UI
[28]. Jackson et al found peripheral diabetes neuropathy
to be borderline predictive of any incident UI (OR 1.7,
95% CI: 1.0 – 3.1) [17]. We did however find an associ-
ation between recently developed diabetes (after E1) and
remission of UI, where development of diabetes between
E1 and E2 was associated with reduced odds of remis-
sion from UI. This could be due to the different type
and severity distribution of UI found in women with dia-
betes [38], where women with diabetes were found to
have a higher prevalence of mixed and severe UI, or
caused by higher prevalence of other risk factors for UI
in women with diabetes (such as overweight). The re-
sults might indicate an overrepresentation of other risk
factors for UI in women with diabetes, since the
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mission of UI no longer was significant after adjustments
for age, BMI, weight change, parity and smoking. The
lack of any significant results in the analyses of having
diabetes in E1 as a risk factor for incidence or remission
of UI could be due to the limited number of diabetes pa-
tients participating in both EPINCONT surveys (n = 176,
of whom 64 reported any UI in E2).
Conclusion
A 16% relative increase in crude UI prevalence was
found in EPINCONT, and average yearly incidence and
remission rates were 1.7% and 3.1% respectively. Known
risk factors for UI such as age, BMI, weight change and
parity were found to be influential on incidence of UI,
remission of UI or both. Getting diabetes between the
two EPINCONT studies reduced the odds of remission
of UI, though only before adjustments. Some of the
increase in UI prevalence in EPINCONT could be
explained by concurrent changes in risk factors in the
study population.
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